Mounjaro®
Starting from £179.99/mo
Start journey Learn moreA runny nose on Wegovy is reported by some people during treatment, and it can feel puzzling when you were expecting stomach-related side effects, not a stuffy face. Semaglutide's most common side effects are gastrointestinal, but upper respiratory symptoms (including a runny nose) do appear in the clinical data. They're generally mild and tend to settle without treatment. As a prescription-only medicine, Wegovy is assessed by a prescriber who will weigh your full symptom picture alongside your health history before any recommendation is made.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture this: a couple of weeks into your new pen, the nausea you'd braced yourself for hasn't been too bad, but your nose has decided to run a marathon. It's an odd side effect to land on because Wegovy's reputation is entirely GI-focused. Yet when you read the Patient Information Leaflet (which the NHS semaglutide medicines page draws from) upper respiratory tract symptoms including a runny nose appear in the listed side effects. They don't feature as prominently as nausea or diarrhoea, which is partly why patients are caught off guard.
The mechanism isn't fully pinned down. Semaglutide's GLP-1 receptors are found across multiple body systems, not only the gut, and some researchers think their activity in the nervous and immune systems may influence nasal secretions in susceptible individuals. That said, this remains an area where the science is still filling in the gaps.
Timing matters too. Many people notice these symptoms around a dose step, and if yours appeared shortly after moving up, that's a meaningful clue. The body's adjustment window after a dose increase is typically a few weeks. If you're planning a holiday or your first increase lands on a long weekend (perhaps a bank holiday Monday) give it a little extra time before drawing conclusions.
Wegovy and runny nose might seem like an unlikely pairing when everything you've read focused on stomach upset. The key distinction is that upper respiratory symptoms on semaglutide sit in a separate category from the gastrointestinal ones: nausea, vomiting, constipation and reflux are dose-dependent and well-characterised; nasal symptoms are less predictable and more varied in who gets them.
If the mucus has an odd or unpleasant smell, that's a slightly different conversation. A bad-smelling nasal discharge while on Wegovy is more likely to reflect a sinus infection or sinusitis running alongside treatment than a direct drug effect. The medicine doesn't cause bacterial infections, so foul-smelling symptoms should be assessed by a clinician rather than waited out.
Some people also notice other sensory changes on Wegovy, including a funny taste in the mouth, which again sits in the upper sensory tract territory. None of these individual symptoms are cause for alarm on their own, but a cluster of new symptoms always warrants a conversation with your prescriber rather than self-managing in silence.
A mild, intermittent runny nose that appeared after starting or increasing Wegovy, and is otherwise untroubling, is not a medical emergency. The MHRA's patient safety guidance for GLP-1 medicines focuses on symptoms that signal something more serious: severe, persistent stomach pain (especially pain that reaches through to your back), signs of dehydration from prolonged vomiting or diarrhoea, allergic reactions, or sudden changes in vision. A runny nose alone is not in that category.
If the nasal symptom is making daily life difficult, is accompanied by fever or facial pain, or simply doesn't ease after a few weeks, tell your prescriber. That's not an overreaction; it's exactly what aftercare is for. You can also report unexpected symptoms directly via the MHRA's Yellow Card scheme, which helps regulators track side effects across the wider population.
For context on what nosebleeds specifically mean on Wegovy (a related but distinct concern) the dedicated page on whether Wegovy can cause nosebleeds is worth reading alongside this one.
If you're confident the runny nose is medicine-related and it's tolerable, the practical approach is simple: give it time, stay hydrated, and keep your prescriber informed at your next check-in. Over-the-counter antihistamines or saline nasal sprays can take the edge off without affecting semaglutide, though any new medicine, even one sold without a prescription, should be mentioned to your prescriber. Drug interactions on Wegovy are manageable, but your prescriber builds the full picture.
Physical activity is often a useful signal too. If running or exercise reliably worsens the symptom, it may be post-nasal drip being aggravated by increased breathing effort. The guide on Wegovy and running covers how exercise intersects with treatment more broadly.
The broader semaglutide overview explains how the medicine works if you want a fuller understanding of why a GLP-1 receptor agonist can produce effects well beyond the digestive system. And for a realistic sense of what the treatment costs (because pricing is often the next question once you're confident about side effects) the Wegovy prices page sets out what a transparent private prescription actually includes.
If you'd like a prescriber to look at your specific symptom history and advise whether to continue, adjust, or simply monitor, speak to our prescribers through a free consultation, a real clinician reviews your answers the same day, not a bot.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.